89.38
-7.19
(-7.45%)
At close: January 10 at 4:00:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 222,346 | 18 |
| Sales | 1,975,301 | 29 |
| Net Shares Purchased (Sold) | -1,752,955 | 47 |
| Total Insider Shares Held | 5M | -- |
| % Net Shares Purchased (Sold) | -26.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| STUELAND KATHERINE Chief Executive Officer | Sale at price 93.34 - 96.39 per share. | Direct | 4,858,119 | Jan 7, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 93.32 - 96.52 per share. | Direct | 3,331,024 | Jan 7, 2025 |
| FEELEY KEVIN Chief Financial Officer | Conversion of Exercise of derivative security at price 32.67 per share. | Direct | 366,165 | Jan 7, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 75.47 - 80.47 per share. | Direct | 1,407,686 | Jan 2, 2025 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 75.08 - 77.04 per share. | Direct | 108,737 | Jan 2, 2025 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 76.75 per share. | Direct | 805,995 | Dec 16, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Dec 16, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 76.75 per share. | Direct | 286,139 | Dec 16, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Dec 16, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 76.37 per share. | Direct | 279,598 | Dec 9, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Dec 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 76.37 per share. | Direct | 86,836 | Dec 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Dec 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 78.39 per share. | Direct | 20,617 | Dec 2, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Nov 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 69.58 - 77.40 per share. | Direct | 1,645,810 | Nov 22, 2024 |
| RYAN JASON C Director | Sale at price 68.36 - 72.26 per share. | Indirect | 3,316,880 | Nov 20, 2024 |
| RYAN JASON C Director | Stock Gift at price 0.00 per share. | Indirect | 0 | Nov 19, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 66.60 - 74.34 per share. | Direct | 3,197,684 | Nov 18, 2024 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Beneficial Owner of more than 10% of a Class of Security | Sale at price 69.78 - 70.78 per share. | Direct | 10,393,723 | Nov 18, 2024 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Beneficial Owner of more than 10% of a Class of Security | Sale at price 75.00 per share. | Direct | 64,935,000 | Oct 31, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 84.02 per share. | Direct | 180,979 | Oct 29, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Oct 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 84.02 per share. | Direct | 23,021 | Oct 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Oct 29, 2024 |
| RUCH JOSHUA Director | -- | Direct | -- | Oct 15, 2024 |
| RUCH JOSHUA Director | -- | Direct | -- | Oct 15, 2024 |
| RYAN JASON C Director | -- | Direct | -- | Oct 15, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 37.59 per share. | Direct | 394,733 | Sep 16, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Sep 16, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 37.59 per share. | Direct | 99,050 | Sep 16, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Sep 16, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 33.33 per share. | Direct | 121,288 | Sep 9, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Sep 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 33.33 per share. | Direct | 29,830 | Sep 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Sep 9, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 31.71 per share. | Direct | 8,308 | Sep 3, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Aug 30, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 33.08 - 34.49 per share. | Direct | 4,756,875 | Aug 19, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 33.95 - 34.76 per share. | Direct | 2,898,314 | Aug 13, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 29.35 - 31.82 per share. | Direct | 3,563,807 | Aug 8, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 33.50 per share. | Direct | 2,976,346 | Jul 31, 2024 |
| STUELAND KATHERINE Chief Executive Officer | Sale at price 33.54 per share. | Direct | 72,245 | Jul 29, 2024 |
| STUELAND KATHERINE Chief Executive Officer | -- | Direct | -- | Jul 29, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 33.86 per share. | Direct | 1,692,890 | Jul 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | Sale at price 33.54 per share. | Direct | 9,190 | Jul 29, 2024 |
| FEELEY KEVIN Chief Financial Officer | -- | Direct | -- | Jul 29, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 33.72 - 33.85 per share. | Direct | 4,560,363 | Jul 26, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 32.29 - 33.46 per share. | Direct | 4,946,935 | Jul 23, 2024 |
| OPKO HEALTH, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 32.93 per share. | Direct | 823,188 | Jul 17, 2024 |
Related Tickers
TEM Tempus AI, Inc
37.52
+0.08%
ACCD Accolade, Inc.
6.83
-0.44%
DOCS Doximity, Inc.
52.10
-5.27%
TXG 10x Genomics, Inc.
15.58
-1.58%
TDOC Teladoc Health, Inc.
9.87
+0.92%
GEHC GE HealthCare Technologies Inc.
84.76
-1.74%
ACON Aclarion, Inc.
0.1173
-15.25%
SLP Simulations Plus, Inc.
28.25
+0.14%
WAY Waystar Holding Corp.
37.49
-0.05%
PGNY Progyny, Inc.
18.76
+2.79%